Universitätsklinikum Tübingen

Lessons learned from a multimodal sensor-based eHealth approach for treating pediatric obsessive-compulsive disorder () Klein CS, Hollmann K, Kühnhausen J, Alt AK, Pascher A, Seizer L, Primbs J, et al. Journal article Castleman’s disease in the rheumatological practice () Schmalzing M, Sander O, Seidl M, Marks R, Blank N, Kötter I, Tiemann M, et al. Journal article Implementation of the new DGRh S2e guideline on diagnostics and treatment of adult-onset Still’s disease in Germany () Friedrich R, Kernder A, Blank N, Ernst D, Henes J, Keyßer G, Klemm P, et al. Journal article Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis () Hollenbach M, Heise C, Abou-Ali E, Gulla A, Auriemma F, Soares K, Leung G, et al. Journal article Results of a multicenter, randomized trial examining a new transition model for post-kidney transplant adolescents (2025) Kreuzer M, Prüfe J, Dierks ML, Müther S, Bethe D, Büscher A, Heindl-Rusai K, et al. Journal article PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma (2025) Zeremski V, Haage TR, Witte HM, Adolph L, Beer SA, Behre G, Jacobs B, et al. Journal article Bridging acute and chronic stress effects on inflammation: protocol for a mixed-methods intensive longitudinal study (2025) Seizer L, Pascher A, Branz S, Schmitt N, Löchner J, Schuller BW, Rohleder N, Renner TJ Journal article Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor (2025) Wegert J, Appenzeller S, Treger TD, Streitenberger H, Ziegler B, Bausenwein S, Vokuhl C, et al. Journal article Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease – Design and rationale of the randomized COMPLETE-NSTEMI trial (2025) Feistritzer HJ, Jobs A, Zeymer U, Schneider S, Lauten P, Ferenc M, Weferling M, et al. Journal article Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial (2025) Gani C, Fokas E, Polat B, Ott O, Diefenhardt M, Königsrainer A, Böke S, et al. Journal article